We presume that some chromatin interactions (e.g. CTCF loops or enhancer–promoter interactions) may be pre-established, prior to gene transcription, in the cirrhotic patients with designated fate for HCC development. The gene discussed is CTCF; the disease is hepatocellular carcinoma.